Publications by authors named "Igor Paliienko"

Claim this Profile
A
A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis.
Michael Yellin, Igor Paliienko, Andra Balanescu, Semen Ter-Vartanian, Vira Tseluyko

Arthritis Rheumยท June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis